Additional confirmation of the Piezo2 channelopathy involved neurocentric DOMS theory [9], and the aforementioned therapeutic paired-associative electromagnetic stimulation DOMS studies [26,27] showed that Piezo2 is the underlying mediator of magnetic stimulation [28], as was theorized earlier [9]. The gene discussed is PIEZO2; the disease is channelopathy.